Oncology

Fluciclovine F 18 (Axumin) is a radioactive diagnostic agent that can be used to detect recurring prostate cancer.

Anthracycline chemotherapy for breast cancer treatment may not cause decline in cognitive function.

Some cancer patients treated with doxorubicin will experience heart damage.

The PI3K/AKT pathway may provide a new therapeutic target for breast cancer combination therapy.

Liver tumors found to stop using fructose.

CD2 is necessary for potent adaptive NK cells.

Discovering lung cancer in the early stage shows significant survival benefits.

Anxiety can cause men with prostate cancer to forgo surveillance for chemotherapy.

MAAT could assist cancer survivors with overcoming memory problems and lessen anxiety associated with memory dysfunction.

Obinutuzumab (Gazyva) is an engineered monoclonal antibody designed to attach to the CD20 protein.

Top news of the day from across the healthcare landscape.

Organ recipients with a history of cancer were 1.5 times more likely to die early from any cause compared with organ recipients without history of cancer.

Opdivo shows overall survival benefit at the 2-year time point compared with docetaxel in advanced non-small cell lung cancer.

Treatment approach may eradicate triple-negative breast cancer.

Use of statins may lower the risk of prostate cancer associated with high fat intake.

Granulin implicated in the spread of cancer from the pancreas to the liver.

Top news of the day from across the health care landscape.

Chimeric antigen receptor (CAR) T-cell therapy has generated a lot of buzz in the drug development world.

Keytruda is a humanized monoclonal antibody that increases the ability of the immune system to detect and fight tumor cells.

Stereotactic body radiation therapy shows 98% cure rate in first-time prostate cancer patients.

The biological mechanisms underlying the association between a successful plasma analysis and the age of non-small cell lung cancer patients are not fully understood.

HPV vaccine found effective in reducing related cancers across all races and ethnic groups.

Top news of the day from across the health care landscape.

Lack of enrollment in clinical trials hinder advancement of cancer therapy.

Cancer diagnosis may potentially cause a decrease in physical function and mental health.

Treatment of elderly patients with multiple myeloma creates unique hurdles for care providers.

Cisplatin kills both rapidly dividing cells and non-dividing cells in the inner ear, which can lead to hearing loss.

Cancer drugs that inhibit class 1 histone deacetylases may reduce excess enlargement of heart muscle cells.